This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Qiagen Gmbh. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Ioanna Andreou: Innovator in RNA Technology
Introduction
Ioanna Andreou is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of RNA technology, particularly in the development of modified short interfering RNA (siRNA) molecules. Her innovative work has the potential to advance therapeutic applications in various medical fields.
Latest Patents
Ioanna Andreou holds a patent for a double-stranded siRNA molecule that comprises a sense strand and an antisense strand, which are essentially complementary to each other. Each strand consists of at least 17 nucleotides, and the siRNA includes at least one overhang at the 5' and/or 3' end. The overhang residues are chemically modified and selected from a specific group of modifications, enhancing the functionality of the siRNA. This patent represents a significant advancement in RNA technology, with applications in gene silencing and therapeutic interventions.
Career Highlights
Ioanna is currently employed at Qiagen GmbH, a leading company in the field of molecular diagnostics and sample preparation. Her work at Qiagen has allowed her to focus on innovative solutions that address complex biological challenges. With her expertise, she has contributed to the development of cutting-edge technologies that are essential for research and clinical applications.
Collaborations
Throughout her career, Ioanna has collaborated with notable colleagues, including Stefan Pitsch and Evelyne Muller. These collaborations have fostered a dynamic research environment, enabling the exchange of ideas and the advancement of innovative projects.
Conclusion
Ioanna Andreou is a trailblazer in RNA technology, with a patent that showcases her innovative spirit and dedication to scientific advancement. Her work at Qiagen GmbH and collaborations with esteemed colleagues highlight her commitment to pushing the boundaries of molecular research.